Inhibrx Biosciences, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| VIKING GLOBAL INVESTORS LP | 11/14/2025 | 1.79 M | $60.21 M | 0.00% | 11.56% |
| PERCEPTIVE ADVISORS LLC | 11/14/2025 | 1.33 M | $44.72 M | 35.77% | 8.58% |
| SANOFI | 11/04/2025 | 1.16 M | $39.00 M | 0.00% | 7.49% |
| HIGHTOWER ADVISORS, LLC | 11/07/2025 | 871.76 K | $29.36 M | 0.00% | 5.64% |
| BLACKROCK, INC. | 11/12/2025 | 684.75 K | $23.06 M | -6.04% | 4.43% |
| VANGUARD GROUP INC | 11/07/2025 | 594.92 K | $20.04 M | -0.59% | 3.85% |
| MORGAN STANLEY | 11/14/2025 | 442.86 K | $14.92 M | 1,492.55% | 2.86% |
| SOFINNOVA INVESTMENTS, INC. | 11/14/2025 | 440.09 K | $14.82 M | -37.90% | 2.85% |
| WOODLINE PARTNERS LP | 11/14/2025 | 336.59 K | $11.34 M | -49.22% | 2.18% |
| MILLENNIUM MANAGEMENT LLC | 11/14/2025 | 297.82 K | $10.03 M | 7.99% | 1.93% |
| PFM HEALTH SCIENCES, LP | 11/14/2025 | 239.64 K | $8.07 M | -1.89% | 1.55% |
| CALIGAN PARTNERS LP | 11/14/2025 | 236.38 K | $7.96 M | 100.00% | 1.53% |
| GEODE CAPITAL MANAGEMENT, LLC | 11/12/2025 | 221.92 K | $7.48 M | -1.79% | 1.43% |
| STATE STREET CORP | 11/14/2025 | 203.92 K | $6.87 M | -0.51% | 1.32% |
| READYSTATE ASSET MANAGEMENT LP | 11/07/2025 | 170.16 K | $5.73 M | 534.11% | 1.10% |
| KENNEDY CAPITAL MANAGEMENT LLC | 11/13/2025 | 161.91 K | $5.45 M | -8.69% | 1.05% |
| SCHONFELD STRATEGIC ADVISORS LLC | 11/14/2025 | 97.38 K | $3.28 M | -37.09% | 0.63% |
| NORTHERN TRUST CORP | 11/14/2025 | 92.66 K | $3.12 M | -5.15% | 0.60% |
| BOOTHBAY FUND MANAGEMENT, LLC | 11/14/2025 | 78.81 K | $2.65 M | 179.18% | 0.51% |
| JANE STREET GROUP, LLC | 11/14/2025 | 62.94 K | $2.12 M | 224.89% | 0.41% |
| CAPTION MANAGEMENT, LLC | 11/14/2025 | 57.50 K | $1.94 M | 100.00% | 0.37% |
| CITADEL ADVISORS LLC | 11/14/2025 | 57.19 K | $1.93 M | 100.00% | 0.37% |
| SUMMITTX CAPITAL, L.P. | 11/14/2025 | 54.14 K | $1.82 M | 100.00% | 0.35% |
| BANK OF NEW YORK MELLON CORP | 11/03/2025 | 50.13 K | $1.69 M | -0.70% | 0.32% |
| GROUPE LA FRANCAISE | 11/13/2025 | 47.33 K | $1.59 M | -37.66% | 0.31% |
| SLOTNIK CAPITAL, LLC | 11/13/2025 | 41.40 K | $1.39 M | -77.52% | 0.27% |
| WETHERBY ASSET MANAGEMENT INC | 11/14/2025 | 40.66 K | $1.37 M | 0.00% | 0.26% |
| FMR LLC | 11/13/2025 | 39.33 K | $1.32 M | 0.66% | 0.25% |
| RUSSELL INVESTMENTS GROUP, LTD. | 11/13/2025 | 38.13 K | $1.28 M | 27.14% | 0.25% |
| ARROWMARK COLORADO HOLDINGS LLC | 11/14/2025 | 35.18 K | $1.18 M | -2.84% | 0.23% |
| BIRCHVIEW CAPITAL, LP | 11/13/2025 | 31.70 K | $1.07 M | -1.28% | 0.20% |
| WELLINGTON MANAGEMENT GROUP LLP | 11/14/2025 | 29.76 K | $1.00 M | 100.00% | 0.19% |
| CREDIT INDUSTRIEL ET COMMERCIAL | 11/07/2025 | 28.96 K | $975.31 K | -54.91% | 0.19% |
| ACADIAN ASSET MANAGEMENT LLC | 11/13/2025 | 28.45 K | $957.00 K | -76.32% | 0.18% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 11/10/2025 | 27.79 K | $936.07 K | 0.00% | 0.18% |
| MARSHALL WACE, LLP | 11/13/2025 | 27.24 K | $917.51 K | 100.00% | 0.18% |
| GOLDMAN SACHS GROUP INC | 11/14/2025 | 25.97 K | $874.54 K | 134.16% | 0.17% |
| MERIDIAN WEALTH ADVISORS, LLC | 11/12/2025 | 25.00 K | $842.00 K | 0.00% | 0.16% |
| EMPIRICAL FINANCIAL SERVICES, LLC D.B.A. EMPIRICAL WEALTH MANAGEMENT | 11/10/2025 | 22.58 K | $760.63 K | 0.00% | 0.15% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 11/14/2025 | 20.60 K | $693.81 K | 100.00% | 0.13% |
| ALLIANCEBERNSTEIN L.P. | 11/14/2025 | 19.23 K | $647.67 K | -5.83% | 0.12% |
| BANK OF AMERICA CORP /DE/ | 11/14/2025 | 17.83 K | $600.58 K | 95.31% | 0.12% |
| NUVEEN, LLC | 11/12/2025 | 17.58 K | $592.23 K | -17.11% | 0.11% |
| INVESCO LTD. | 11/13/2025 | 17.57 K | $591.89 K | 30.26% | 0.11% |
| MARINER, LLC | 11/14/2025 | 17.34 K | $584.08 K | 45.07% | 0.11% |
| FRANKLIN RESOURCES INC | 11/13/2025 | 17.16 K | $578.08 K | -22.58% | 0.11% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 11/14/2025 | 16.50 K | $555.72 K | 0.00% | 0.11% |
| ACUTA CAPITAL PARTNERS, LLC | 11/14/2025 | 16.38 K | $551.58 K | 100.00% | 0.11% |
| CAPTION MANAGEMENT, LLC | 11/14/2025 | 15.51 K | $522.48 K | -92.22% | 0.10% |
| ETHIC INC. | 10/17/2025 | 14.49 K | $487.92 K | -7.95% | 0.09% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Inhibrx Biosciences, Inc. institutional Ownership - FAQ's
During the previous two years, 126 institutional investors and hedge funds held shares of Inhibrx Biosciences, Inc.. The most heavily invested institutionals were:
VIKING GLOBAL INVESTORS LP: 1.79 M
PERCEPTIVE ADVISORS LLC: 1.33 M
Sanofi: 1.16 M
HighTower Advisors, LLC: 871,759
BlackRock, Inc.: 684,746
VANGUARD GROUP INC: 594,918
67.86% of Inhibrx Biosciences, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 11.40 M shares in the last 24 months. This purchase volume represents approximately $406.25 M in transactions.